NDC 0597-0435 – Pradaxa
Dabigatran Etexilate Mesylate 40 mg/1 · Pellet · Oral
Product NDC0597-0435
Product details
- Brand name
- Pradaxa
- Generic name
- Dabigatran etexilate
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- Pellet
- Route
- Oral
- Marketing category
- NDA · NDA214358
- Marketed since
- March 16, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Direct Thrombin Inhibitor
Active ingredients
- Dabigatran Etexilate Mesylate 40 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0597-0435-96 | 1 BAG in 1 CARTON (0597-0435-96) / 60 PELLET in 1 BAG | Mar 16, 2022 |
Other Pradaxa products
- 0597-0425 Dabigatran Etexilate Mesylate 20 mg/1 · Pellet · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0430 Dabigatran Etexilate Mesylate 30 mg/1 · Pellet · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0440 Dabigatran Etexilate Mesylate 50 mg/1 · Pellet · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0445 Dabigatran Etexilate Mesylate 110 mg/1 · Pellet · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0450 Dabigatran Etexilate Mesylate 150 mg/1 · Pellet · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0108 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Boehringer Ingelheim Pharmaceuticals Inc.
- 0597-0355 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Boehringer Ingelheim Pharmaceuticals Inc.
- 0597-0360 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Boehringer Ingelheim Pharmaceuticals Inc.